High Yield Branched Puromycin Linker Design Enables Efficient cDNA Display and Chemical Modification of Peptides
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Simon Schneider und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Puromycin, Peptides, DNA, Complementary. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung, InvestBW.
Abstract (Originalsprache)
Peptide chemical modification is a valuable technique for improving peptide stability and bioactivity, particularly in drug discovery applications. Here, we report the development of a novel linker junction strategy using strain‐promoted azide‐alkyne cycloaddition (SPAAC) that enables the efficient formation of branched puromycin linkers with an average yield of 97%. This approach represents an improvement over traditional Michael‐Addition methods, which typically yield ~15%–20%. The high yield of the SPAAC reaction and the near absence of by‐products make the linkage by click reaction easy to purify. We demonstrate the utility of our linker design by successfully performing cDNA display and chemical modification strategies such as bicyclization of peptides. Our study demonstrates the functionality of the cDNA display system with the newly incorporated junction. In addition, the successful introduction of peptide bicyclization via tris‐bromomethyl‐benzene (TBMB) in cDNA display serves as a proof‐of‐concept for complex chemical modifications. Furthermore, the position of puromycin, which disrupts protein biosynthesis, has been determined. This approach offers novel insights into the discovery of chemically modified peptides and has the potential to accelerate the development of peptide‐based therapeutics and diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
- German Cancer Research Center, Heidelberg, Germany.
- Faculty of Biology, University of Freiburg, Freiburg, Germany.
Förderung
- Wilhelm Sander-Stiftung
- InvestBW
Zitieren
APA
Schneider, S., Boll, M., Eder, M., & Eder, A. C. (2026). High Yield Branched Puromycin Linker Design Enables Efficient cDNA Display and Chemical Modification of Peptides. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70164
Vancouver
Schneider S, Boll M, Eder M, Eder AC. High Yield Branched Puromycin Linker Design Enables Efficient cDNA Display and Chemical Modification of Peptides. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70164
BibTeX
@article{Schneider2026,
author = {Schneider, Simon and Boll, Melanie and Eder, Matthias and Eder, Ann-Christin},
title = {High Yield Branched Puromycin Linker Design Enables Efficient cDNA Display and Chemical Modification of Peptides},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70164}
}
EUVIMED